Brazil gives nod for Chinese COVID-19 vaccine trial


Source: thehindu.com thehindu.com

Key Topics in this News Article:

News Snapshot:

Anvisa's approval comes after Brazil surpassed 1.5 million confirmed cases of COVID-19, Brazilian health regulator Anvisa on Friday approved clinical trials of a potential coronavirus vaccine developed by China's Sinovac, according to an official gazette publication. The study, first announced on June 11, is led by Instituto Butantan, a research center funded by the state of Sao Paulo. The agreement with Sinovac includes not only trials but also the transference of technology to produce the potential vaccine locally. On June 29, Sao Paulo state Governor Joao Doria said 9,000 volunteers have already been registered to test the vaccine against COVID-19...